Floatz logo

Ex Vivo-Activated Autologous Lymph Node Lymphocytes

Cancer Fatigue

M.D. Anderson Cancer CenterCell therapyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Cancer Fatigue cohort.

Asset / SponsorPhaseRating
Anamorelin
M.D. Anderson Cancer Center
Phase 2CCC

Same molecule, other indications

Ex Vivo-Activated Autologous Lymph Node Lymphocytes is also rated in:

anemiaDormant
B
Indicative ·
57 / 100
View asset →
FeverDormant
B
Indicative ·
57 / 100
View asset →
infectious diseaseDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →